Less than two years after arriving at the University of Michigan, physician-scientist Navin Rajput Mahadevan, MD, PhD, has been named a Taubman Emerging Scholar, receiving five years of support to advance research aimed at improving outcomes for patients with small cell lung cancer, one of the deadliest forms of cancer. Mahadevan, an assistant professor of pathology, will use the award to investigate how some small cell lung cancers become recognizable to the immune system and how that knowledge can be used to develop new treatments. The Taubman Emerging Scholar Award provides $50,000 annually for five years, funding laboratory supplies, reagents, and specialized analyses needed to move the project forward.
U-M neuropathologist Sriram Venneti, MD, PhD, was recently featured in The New York Times for his research on diffuse midline glioma (DMG), one of the deadliest pediatric brain cancers.
On May 6, 2026, Dr. Sean Li, Associate Professor and Director of the Pathology Residency Program, received the GME Program Director Excellence Award from the University of Michigan Medical School. This award recognizes one of the 100+ residency or fellowship directors who has had a significant impact on the quality of education in their respective training program. The award criteria include a demonstrated commitment to teaching through dedication, innovation, creativity, leadership, teamwork, advocacy, crisis management, role modeling, and overall impact on the program.